History | Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 147 KB)

Published:

09 December 2020

Declaration of interests

Register of interests (PDF 383 KB)

Published:

09 December 2020

Final draft guidance

Final draft guidance
Final appraisal document (PDF 303 KB)

Published:

10 November 2020
Committee papers (PDF 6.58 MB)

Published:

10 November 2020
Public committee slides (PDF 1.15 MB)

Published:

10 November 2020
Final appraisal document Managed Access Agreement (PDF 416 KB)

Published:

10 November 2020

Invitation to participate

Final scope (PDF 224 KB)

Published:

07 August 2019
Final stakeholder list (PDF 184 KB)

Published:

07 August 2019
Equality Impact Assessment (Guidance development) (PDF 128 KB)

Published:

07 August 2019
Draft scope and provisional stakeholder list comments table (post-referral) (MSWord 41 KB)

Published:

22 August 2019

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 231 KB)

Published:

29 May 2019
Draft matrix post referral (PDF 187 KB)

Published:

29 May 2019